Please use this identifier to cite or link to this item: https://doi.org/10.1007/s002800050427
Title: Intracellular localization and intercellular heterogeneity of the human DNA repair protein O6-methylguanine-DNA methyltransferase
Authors: Belanich, M.
Randall, T.
Pastor, M.A.
Kibitel, J.T.
Alas, L.G.
Dolan, M.E.
Schold Jr., S.C.
Gander, M.
Lejeune, F.J.
Li, B.F.L. 
White, A.B.
Wasserman, P.
Citron, M.L.
Yarosh, D.B.
Keywords: 1,3-Bis(2-chlorethyl)-1-nitrosourea
Alkyltransferase
Carmustine
O6-Benzylguanine
Temozolomide
Issue Date: 1996
Citation: Belanich, M., Randall, T., Pastor, M.A., Kibitel, J.T., Alas, L.G., Dolan, M.E., Schold Jr., S.C., Gander, M., Lejeune, F.J., Li, B.F.L., White, A.B., Wasserman, P., Citron, M.L., Yarosh, D.B. (1996). Intracellular localization and intercellular heterogeneity of the human DNA repair protein O6-methylguanine-DNA methyltransferase. Cancer Chemotherapy and Pharmacology 37 (6) : 547-555. ScholarBank@NUS Repository. https://doi.org/10.1007/s002800050427
Abstract: O6-Methylguanine-DNA methyltransferase (MGMT) is a DNA repair protein that removes alkyl adducts from DNA and may be important in tumor resistance to alkylation chemotherapy. MGMT was visualized in human cells and tumor tissues with monoclonal antibodies against MGMT and immunofluorescence microscopy, and fluorescent signals were quantified by digital image analysis. MGMT was found both in the cytoplasm and the nucleus, and in either locale the protein reacts with alkylated DNA bases and becomes inactivated and lost from the cell. Cell lines in culture and xenografts showed a broad normal distribution of nuclear MGMT levels, but human brain tumors often showed a skewed distribution, with a significant fraction of cells with high levels of MGMT. O6-Benzylguanine, a suicide substrate inactivator for MGMT activity, reduced MGMT in human cells and in a mouse xenograft to levels undetectable by antibody assay 1 h post-treatment. In melanoma specimens taken from a patient 3 h post-treatment with temozolomide, MGMT levels were reduced by 70%. This quantitative immunofluorescence assay can be used to monitor MGMT and its depletion in human tumors to improve the use of alkylating agents in cancer chemotherapy.
Source Title: Cancer Chemotherapy and Pharmacology
URI: http://scholarbank.nus.edu.sg/handle/10635/115780
ISSN: 03445704
DOI: 10.1007/s002800050427
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

61
checked on Dec 12, 2018

WEB OF SCIENCETM
Citations

52
checked on Dec 12, 2018

Page view(s)

50
checked on Dec 7, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.